Skip to main content

Table 2 Patients’ demographics, clinical characteristics, laboratory data, and imaging features of both groups

From: Diagnostic performance of chest CT in differentiating COVID-19 from other causes of ground-glass opacities

  COVID-19
(n = 80)
Non-COVID-19
(n = 100)
P value
Age 46.48 ± 16.09 48.94 ± 18.97 0.131
Sex
 Male 49 (61.25%) 55 (55%) 0.108
 Female 31 (38.75%) 45 (45%) 0.098
Clinical data
 Fever 72 (90%) 62 (62%) < 0.001
 Cough and dyspnea 65 (81.25%) 85 (85%) 0.218
 GIT manifestations 15 (18.75%) 5 (5%) < 0.001
Laboratory findings
 Leukocytosis 12 (15%) 56 (56%) < 0.001
 Lymphopenia 44 (55%) 21 (21%) < 0.001
CT features
 Isolated GGO 17 (21.5%) 13 (13%) 0.043
 Consolidation 54 (65%) 72 (72%) 0.268
 Crazy-paving 15 (18.75%) 21 (21%) 0.369
 Reversed halo 9 (11.25%) 3 (3%) 0.005
 Subpleural bands 24 (30%) 19 (19%) 0.048
 Vascular thickening 29 (36.25%) 17 (17%) 0.013
 Traction bronchiectasis 13 (16.25%) 39 (39%) 0.005
 Pulmonary nodules 17 (21.5%) 41 (41%) < 0.001
 Lymphadenopathy 0 (0%) 12 (12%) < 0.001
 Pleural effusion 4 (5%) 32 (32%) < 0.001
Laterality
 Unilateral 12 (15%) 19 (19%) 0.323
 Bilateral 68 (85%) 81 (81%) 0.297
Lobar affection
 Upper 43 (53.75%) 67 (67%) 0.039
 Lower 71 (88.75%) 65 (65%) 0.005
Distribution
 Peripheral 63 (78.75%) 46 (46%) < 0.001
 Central 2 (2.5%) 13 (13%) < 0.001
 Diffuse 15 (18.75%) 41 (41%) < 0.001